1. Home
  2. TLX vs RELY Comparison

TLX vs RELY Comparison

Compare TLX & RELY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • RELY
  • Stock Information
  • Founded
  • TLX 2015
  • RELY 2011
  • Country
  • TLX Australia
  • RELY United States
  • Employees
  • TLX N/A
  • RELY N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • RELY Computer Software: Prepackaged Software
  • Sector
  • TLX Health Care
  • RELY Technology
  • Exchange
  • TLX Nasdaq
  • RELY Nasdaq
  • Market Cap
  • TLX 4.0B
  • RELY 3.9B
  • IPO Year
  • TLX N/A
  • RELY 2021
  • Fundamental
  • Price
  • TLX $9.51
  • RELY $18.53
  • Analyst Decision
  • TLX Strong Buy
  • RELY Buy
  • Analyst Count
  • TLX 3
  • RELY 9
  • Target Price
  • TLX $22.33
  • RELY $27.22
  • AVG Volume (30 Days)
  • TLX 217.0K
  • RELY 4.5M
  • Earning Date
  • TLX 01-01-0001
  • RELY 10-29-2025
  • Dividend Yield
  • TLX N/A
  • RELY N/A
  • EPS Growth
  • TLX N/A
  • RELY N/A
  • EPS
  • TLX 0.04
  • RELY 0.06
  • Revenue
  • TLX $664,225,558.00
  • RELY $1,461,898,000.00
  • Revenue This Year
  • TLX N/A
  • RELY $30.78
  • Revenue Next Year
  • TLX N/A
  • RELY $20.93
  • P/E Ratio
  • TLX $298.01
  • RELY $294.49
  • Revenue Growth
  • TLX 55.35
  • RELY 35.12
  • 52 Week Low
  • TLX $9.48
  • RELY $12.43
  • 52 Week High
  • TLX $30.36
  • RELY $27.32
  • Technical
  • Relative Strength Index (RSI)
  • TLX 31.15
  • RELY 50.58
  • Support Level
  • TLX $12.12
  • RELY $18.09
  • Resistance Level
  • TLX $12.58
  • RELY $18.65
  • Average True Range (ATR)
  • TLX 0.45
  • RELY 0.48
  • MACD
  • TLX 0.01
  • RELY -0.06
  • Stochastic Oscillator
  • TLX 0.98
  • RELY 21.36

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Share on Social Networks: